These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26077571)

  • 21. Microvascular dysfunction: causative role in the association between hypertension, insulin resistance and the metabolic syndrome?
    Serné EH; de Jongh RT; Eringa EC; Ijzerman RG; de Boer MP; Stehouwer CD
    Essays Biochem; 2006; 42():163-76. PubMed ID: 17144887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin resistance: the clinical spectrum.
    Mantzoros CS; Flier JS
    Adv Endocrinol Metab; 1995; 6():193-232. PubMed ID: 7671097
    [No Abstract]   [Full Text] [Related]  

  • 23. Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study.
    Gaillard R; Steegers EA; Duijts L; Felix JF; Hofman A; Franco OH; Jaddoe VW
    Hypertension; 2014 Apr; 63(4):683-91. PubMed ID: 24379180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resistance exercise training: its role in the prevention of cardiovascular disease.
    Braith RW; Stewart KJ
    Circulation; 2006 Jun; 113(22):2642-50. PubMed ID: 16754812
    [No Abstract]   [Full Text] [Related]  

  • 25. [Insulin resistance and vascular function].
    Naruse M; Tanabe A; Takagi S; Tago K; Takano K
    Nihon Rinsho; 2000 Feb; 58(2):344-7. PubMed ID: 10707556
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin.
    Polyzos SA; Kountouras J; Zavos C; Stergiopoulos C
    Med Hypotheses; 2010 Jun; 74(6):1089-90. PubMed ID: 20080361
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiometabolic risk and female sexual health: the Princeton III summary.
    Miner M; Esposito K; Guay A; Montorsi P; Goldstein I
    J Sex Med; 2012 Mar; 9(3):641-51; quiz 652. PubMed ID: 22372651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship of liver fat content to insulin resistance and metabolic syndrome].
    Yan HM; Gao X; Liu M; Gu Q; Zhang B; Li X
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1255-8. PubMed ID: 18844098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of hypertension in the cardiometabolic syndrome.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G
    J Hypertens; 2009 Mar; 27(3):441-51. PubMed ID: 19262221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The interactions of nonalcoholic fatty liver disease and cardiovascular diseases.
    Perazzo H; Poynard T; Dufour JF
    Clin Liver Dis; 2014 Feb; 18(1):233-48. PubMed ID: 24274877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Dyslipidemia and abdominal obesity: mechanisms and characteristics (Part I)].
    Farnier M
    Arch Mal Coeur Vaiss; 2007 Dec; 100(12):979-84. PubMed ID: 18223510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease.
    Martínez-Clemente M; Clària J; Titos E
    Curr Opin Clin Nutr Metab Care; 2011 Jul; 14(4):347-53. PubMed ID: 21587068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: the metabolic syndrome and non-alcoholic fatty liver disease.
    Loria P; Lonardo A; Carulli L; Verrone AM; Ricchi M; Lombardini S; Rudilosso A; Ballestri S; Carulli N
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():31-6. PubMed ID: 16225469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study.
    Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M
    Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of vascular disease in hypertension with special reference to diabetes.
    Yudkin JS
    Semin Vasc Med; 2002 May; 2(2):139-48. PubMed ID: 16222605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypertension and insulin resistance].
    Voiculescu A; Kutkuhn B; Rösen P; Grabensee B
    Wien Klin Wochenschr; 1997 Oct; 109(19):758-66. PubMed ID: 9441522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and cardiovascular disease.
    Ginsberg HN
    J Clin Invest; 2000 Aug; 106(4):453-8. PubMed ID: 10953019
    [No Abstract]   [Full Text] [Related]  

  • 40. Consequences of change in waist circumference on cardiometabolic risk factors over 9 years: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).
    Balkau B; Picard P; Vol S; Fezeu L; Eschwège E;
    Diabetes Care; 2007 Jul; 30(7):1901-3. PubMed ID: 17468349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.